Sunlenca solution for injection 463.5mg/1.5ml

Regulatory Information

HSA regulatory responsibility and product classification details

RegistrantGILEAD SCIENCES SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Class

Prescription Only

HSA Singapore Classification

Dosage Form

INJECTION, SOLUTION

Route of Administration

SUBCUTANEOUS

ATC Code

J05AX31

Pharmaceutical Manufacturer

GILEAD SCIENCES SINGAPORE PTE. LTD.

Manufacturers

Patheon Italia, S.p.A.

Ingredient Name

Lenacapavir Sodium eqv Lenacapavir

Strength

463.5mg/1.5ml

Drug MonographLenacapavir

SUNLENCA INJ PI.pdf

Approved: February 27, 2025